XML 42 R26.htm IDEA: XBRL DOCUMENT
v3.3.1.900

The Business (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2015
The Business [Abstract] |
Subsidiary | The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly owned and partially owned subsidiaries and affiliates as listed below. All intercompany activities have been eliminated in consolidation.
Entity |  | Percentage of Ownership |  | Location
Caladrius Biosciences, Inc. |  | 100% |  | United States of America
NeoStem Therapies, Inc. |  | 100% |  | United States of America
Stem Cell Technologies, Inc. |  | 100% |  | United States of America
Amorcyte, LLC |  | 100% |  | United States of America
PCT, LLC, a Caladrius Company |  | 100% |  | United States of America
NeoStem Family Storage, LLC |  | 100% |  | United States of America
Athelos Corporation (1) |  | 97% |  | United States of America
PCT Allendale, LLC |  | 100% |  | United States of America
NeoStem Oncology, LLC |  | 100% |  | United States of America
(1) As of December 31, 2015, Becton Dickinson's ownership interest in Athelos Corporation was 2.8%.

X
- Definition The Business [Abstract] + References No definition available. + Details
Name: | clbs_BusinessAbstract
Namespace Prefix: | clbs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Subsidiary [Table Text Block] + References No definition available. + Details
Name: | clbs_SubsidiaryTableTextBlock
Namespace Prefix: | clbs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration